UTILISATION D'UN EXTRAIT DE GINSENG, D'UN GINSENOSIDE ET D'UN DERIVE DE GINSENOSIDE DANS LA PREPARATION D'UN MEDICAMENT OU D'UN PRODUIT DE SOINS DE SANTE PERMETTANT DE TRAITER DESTROUBLES ASSOCIES A UNE INFECTION PAR DES CYTOMEGALOVIRUS
The invention discloses new application of a ginseng extract, ginsenoside anda ginsenosidederivative in the preparation of a medicine for treating HCMV infectionrelated diseases. Therelated diseases comprise HCMV infection caused in the process of treatingcardiovascular andcerebrovascular diseases, organ transplantation, perinatal periods, tumors,burn, AIDS and otherdiseases of patients. Tests prove that the ginseng extract, the ginsenosideand the ginsenosidederivative have a remarkable curative effect, quick response and a small toxicor side effect duringtreatment of HCMV infected diseases, are a medicine or a health product fortreating the HCMVinfection, which is safe, efficient and stable and has a simple preparationprocess, and aresuitable for industrial production and easy to popularize. In the invention, anew medicine sourceis provided for the treatment of the HCMV infection.
